Why do subjects on clinical trials discontinue therapy? Do we really know?

被引：0

作者：

Medeiros, Bruno C. ^{[1
]}

Gale, Robert Peter ^{[2
]}

机构：

[1] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA

[2] Imperial Coll London, Haematol Res Ctr, Div Expt Med, Dept Med, London SW7 2AZ, England

来源：

LEUKEMIA RESEARCH | 2016年 / 51卷

关键词：

Attributions; Clinical trials; ACUTE MYELOID-LEUKEMIA; PANEL;

D O I：

10.1016/j.leukres.2016.10.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：19 / 21

页数：3

共 9 条

[1] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[2] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].

Doehner, Hartmut ;

Estey, Elihu H. ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Burnett, Alan K. ;

Dombret, Herve ;

Fenaux, Pierre ;

Grimwade, David ;

Larson, Richard A. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel A. ;

Sierra, Jorge ;

Tallman, Martin S. ;

Loewenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2010, 115 (03) :453-474

[3] Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer [J].

Gale, RP ;

Park, RE ;

Dubois, R ;

Bitran, JD ;

Buzdar, A ;

Hortobagyi, G ;

Jones, SE ;

Lazar, GS ;

Spitzer, G ;

Swain, SM ;

Vaughn, CB ;

Vogel, CE ;

Martino, S .

CLINICAL TRANSPLANTATION, 2000, 14 (01) :32-41

[4] Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 [J].

Gamis, Alan S. ;

Alonzo, Todd A. ;

Meshinchi, Soheil ;

Sung, Lillian ;

Gerbing, Robert B. ;

Raimondi, Susana C. ;

Hirsch, Betsy A. ;

Kahwash, Samir B. ;

Heerema-McKenney, Amy ;

Winter, Laura ;

Glick, Kathleen ;

Davies, Stella M. ;

Byron, Patti ;

Smith, Franklin O. ;

Aplenc, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3021-+

[5]

Lindquist K, 2009, J CLIN ONCOL, V27

[6] Design and endpoints of clinical trials in hepatocellular carcinoma [J].

Llovet, Josep M. ;

Di Bisceglie, Adrian M. ;

Bruix, Jordi ;

Kramer, Barnett S. ;

Lencioni, Riccardo ;

Zhu, Andrew X. ;

Sherman, Morris ;

Schwartz, Myron ;

Lotze, Michael ;

Talwalkar, Jayant ;

Gores, Gregory J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (10) :698-711

[7]

Mahoney M.R., 2005, J CLIN ONCOL, V23

[8] Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia [J].

Miller, Tamara P. ;

Li, Yimei ;

Kavcic, Marko ;

Troxel, Andrea B. ;

Huang, Yuan-Shun V. ;

Sung, Lillian ;

Alonzo, Todd A. ;

Gerbing, Robert ;

Hall, Matt ;

Daves, Marla H. ;

Horton, Terzah M. ;

Pulsipher, Michael A. ;

Pollard, Jessica A. ;

Bagatell, Rochelle ;

Seif, Alix E. ;

Fisher, Brian T. ;

Luger, Selina ;

Gamis, Alan S. ;

Adamson, Peter C. ;

Aplenc, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) :1537-+

[9] Adverse event reporting in publications compared with sponsor database for cancer clinical trials [J].

Scharf, Orit ;

Colevas, A. Dimitrios .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3933-3938

← 1 →